Unlocking the Ozempic Enigma: Celebrities’ Secret to Weight Loss Revealed!

Ozempic, approved in 2017 for treating type 2 diabetes, has a higher weight-loss dose called Wegovy, sanctioned in 2021. Both contain semaglutide, requiring weekly injections. They boost the appetite-suppressing hormone GLP-1 to regulate blood sugar. Despite FDA approval for diabetes, Ozempic is prescribed off-label for weight loss, often not covered by insurance. The off-label use faces challenges, as insurers might cease coverage for at-risk patients without a diabetes diagnosis after 2023. Out-of-pocket costs can exceed $1,000 monthly without insurance